Publication | Closed Access
The Results of Switching between 2 Anti-VEGF Drugs, Bevacizumab and Ranibizumab, in the Treatment of Neovascular Age-related Macular Degeneration
25
Citations
18
References
2013
Year
The ranibizumab-only group and the switching from bevacizumab to ranibizumab group seemed superior to the ranibizumab to bevacizumab group.
| Year | Citations | |
|---|---|---|
Page 1
Page 1